Omega Pharma NV:企業の戦略・SWOT・財務情報

◆英語タイトル:Omega Pharma NV - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4473
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,100見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥69,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Omega Pharma NV – Strategy, SWOT and Corporate Finance Report
Summary

Omega Pharma NV – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Omega Pharma NV (Omega or ‘the company’), is a subsidiary of Perrigo Company plc, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. Omega is headquartered in Nazareth, Belgium.

Scope

- Detailed information on Omega Pharma NV required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis
- An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments
- Intelligence on Omega Pharma NV’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Omega Pharma NV, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Omega Pharma NV and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Omega Pharma NV as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Omega Pharma NV’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Omega Pharma NV: Company Overview 7
Omega Pharma NV: Overview and Key Facts 7
Omega Pharma NV: Overview 7
Omega Pharma NV: Key Facts 7
Omega Pharma NV: Key Employees 9
Omega Pharma NV: Major Products and Services 10
Omega Pharma NV: Company History 11
Omega Pharma NV: Management Statement 14
Omega Pharma NV: Locations and Subsidiaries 15
Omega Pharma NV: Key Competitors 16
Omega Pharma NV: Company Analysis 17
Omega Pharma NV: Business Description 17
Omega Pharma NV: SWOT Analysis 18
Omega Pharma NV: SWOT Overview 18
Omega Pharma NV: Strengths 18
Omega Pharma NV: Weaknesses 19
Omega Pharma NV: Opportunities 19
Omega Pharma NV: Threats 20
Omega Pharma NV: Corporate Financial Deals Activity 21
Omega Pharma NV: Financial Deals Overview 21
Omega Pharma NV: Targets and Partners 23
Omega Pharma NV: Top Deals 2014 – 2018YTD* 24
Omega Pharma NV: Partnership 25
Omega Pharma NV: Private Equity and Ownership 26
Appendix 27
Contact Us 27
Methodology 27
About MarketLine 28

List of Tables
Table 1: Omega Pharma NV: Key Facts
Table 2: Omega Pharma NV: Key Employees
Table 3: Omega Pharma NV: Locations and Subsidiaries
Table 4: Omega Pharma NV: Key Competitors
Table 5: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Omega Pharma NV: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Omega Pharma NV: Targets and Partners
Table 8: Omega Pharma NV: Top Deals 2014 - 2018YTD*
Table 9: Omega Pharma NV: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 10: Omega Pharma NV: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 11: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 12: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Omega Pharma NV: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Omega Pharma NV: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Omega Pharma NV: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Omega Pharma NV:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析
    Summary Samsung Electronics Co., Ltd. (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, print …
  • Fanhua Inc:企業のM&A・事業提携・投資動向
    Fanhua Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fanhua Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • North Asia Strategic Holdings Limited
    North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • The Home Depot, Inc.:企業の戦略・SWOT・財務情報
    The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pacific Gas and Electric Co-石油・ガス分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Conco, Inc.:企業の戦略・SWOT・財務情報
    Conco, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ra Pharmaceuticals Inc (RARX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • FirstEnergy Corp:企業の発電所・SWOT分析2018
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Immatics Biotechnologies GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Immatics Biotechnologies GmbH (Immatics) is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs …
  • Syneos Health Inc:企業の戦略・SWOT・財務分析
    Syneos Health Inc - Strategy, SWOT and Corporate Finance Report Summary Syneos Health Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Jiangxi Copper Company Limited:戦略・SWOT・企業財務分析
    Jiangxi Copper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jiangxi Copper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Avacta Group Plc (AVCT):企業の財務・戦略的SWOT分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • The Bank of New York Mellon Corporation:企業のM&A・事業提携・投資動向
    The Bank of New York Mellon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of New York Mellon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw mat …
  • Robert Half International Inc.:企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • CVD Equipment Corp (CVV):企業の財務・戦略的SWOT分析
    Summary CVD Equipment Corp (CVD) is a technology company that manufactures, designs, and develops equipment and process solutions. The company’s product portfolio includes research and development equipments, gas and chemicals systems, production process system, automation equipments, cluster tools, …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆